Keywords: Affymax, Janssen, Johnnson & Johnson, Peginesatide, Anemia, Takeda

Affymax and Janssen Biotech enter $13 million peginesatide patent settlement

Article | 11 November 2011

Print This

US biotech firm Affymax (Nasdaq: AFFY) says it has reached a global settlement agreement with Janssen Biotech, a subsidiary of ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in